About Author : Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With experience in technical and niche writing, he was encouraged to opt for a career in content writing and now pens down articles pertaining to market research, industry news and business trends.



Contribution by Pankaj Singh

Everest Medicines Announces Cefepime-Taniborbactam Phase 1 Results

Everest Medicines announced the top-line results from the Phase 1 clinical trial of Taniborbactam with cefepime for treating infections caused by multi-drug resistant pathogens in China. Everest Medicines is a biopharmaceutical company that develops ...

Read More
EP Global Commerce makes offer to increase stake in Metro Cash & Carry

EP Global Commerce, the acquisition vehicle of Slovak and Czech investors, is reportedly launching a new takeover offer to raise its stake in Metro Cash & Carry, a renowned German wholesaler. The new takeover bid aims to increase the company&rsqu...

Read More
Takeda Pharma announces results from its Phase 3 TOURMALINE-MM2 trial

Takeda Pharmaceutical Company Ltd, a renowned Japanese pharmaceutical company, has reportedly announced the outcome of Phase 3 TOURMALINE-MM2 trial that assesses the combination of ixazomib (NINLARO) and lenalidomide, dexamethasone versus dexamethaso...

Read More
Suda Pharmaceuticals Secures Australian Patent for Anagrelide

The shares for Suda Pharmaceuticals were up by 13% after the company received a patent for Anagrelide from the Australian Patent Office. The patent is named as Prevention and Treatment of Metastatic Disease in Thrombocytotic Cancer Patients and will ...

Read More
Novartis announces outcomes from Phase III IRIDIUM study for asthma

Novartis International AG, one of the leading multinational healthcare firms, has reportedly announced outcomes from the crucial Phase III IRIDIUM study of ‘Enerzair Breezhaler’ at ERS( European Respiration Society) International Congress...

Read More
Novartis announces outcomes from Phase III IRIDIUM study for asthma

Novartis International AG, one of the leading multinational healthcare firms, has reportedly announced outcomes from the crucial Phase III IRIDIUM study of ‘Enerzair Breezhaler’ at ERS( European Respiration Society) International Congress...

Read More
Flipkart Wholesale to Launch Services in Bengaluru, Gurugram and Delhi

Flipkart Wholesale, the B2B unit of the Walmart-owned e-commerce firm has launched operations beginning with a fashion segment that focuses on apparel and footwear, two months after taking over Walmart’s Indian business.  Flipkart Wholesa...

Read More
Vir Biotech and GSK join the race find COVID-19 antibody treatment

As the entire world awaits a COVID-19 vaccine, the next big thing in battling the disease could come from a class of biotech therapies such as antibodies designed precisely to attack this virus. As per the latest news, GlaxoSmithKline Plc. and V...

Read More
Walmart announces the launch of Walmart+ to provide free delivery

The world’s biggest retailer Walmart has reportedly announced the launch of its ‘Walmart+’ membership program to provide free delivery to its customers. The program directly aims at challenging the e-commerce giant, Amazon, and will...

Read More
Innovent unveils phase 1/2 clinical study results of PCSK9 antibody

Innovent Biologics, a renowned biopharmaceutical firm that develops, produces, and commercializes innovative medicines to treat metabolic, oncology, autoimmune as well as other prominent diseases, has reportedly announced that results from its Phase ...

Read More
American Airlines asks Federal help, plans to cut off 19,000 workers

After months of warning about forthcoming layoffs once their pandemic bailout expires, American Airlines Inc., is getting closer to making the job cuts. The airline has warned that it will send 19,000 employees off or furlough involuntarily as of 1 O...

Read More
GeoVax to initiate Phase 1 combination therapy trial with MVA62B

GeoVax Labs, Inc., a U.S-based biotechnology firm that focuses on vaccines and immunotherapies for cancer and other infectious, has recently revealed that it has initiated the Phase 1 clinical trial of combination therapy in HIV-infected ad...

Read More
Trump announces emergency authorization for treating COVID-19 patients

U.S. President Donald Trump has reportedly announced emergency authorization for the use of convalescent plasma in the treatment of COVID-19. While Trump reportedly regarded the move to be a breakthrough, one of his top health officials described it ...

Read More
Pfizer/BioNTech evaluates BNT162b2 for large scale clinical trial

The ongoing coronavirus outbreak has brought about major changes to every aspect of life. In times like these, the need to develop a novel treatment for COVID-19 disease is of paramount importance. In a bid to develop an efficient vaccine, Pfizer Inc...

Read More
Serum Institute of India begins Phase 2/3 trials of COVID-19 vaccine

The pharmaceutical company plans to conduct clinical trials at 17 sites across the country Serum Institute of India (SII), an Indian pharmaceutical company that develops immunobiological drugs and vaccines, has recently began the Phase II/III clini...

Read More
M&S to adopt a leaner business model; shed around 7,000 jobs in the UK

Marks & Spencer (M&S), a renowned British retail company, has recently announced that it is planning to cut 7,000 jobs to mitigate heavy losses incurred due to the COVID-19 crisis. The announcement comes as a big blow for Britain’s alre...

Read More
U.S FDA approves Satralizumab for the treatment of NMOSD patients

Genentech Inc., one of leading biotechnology corporations which became a subsidiary of Roche in 2009, has reportedly announced that the U.S FDA (Food and Drug Administration) has reportedly approved Satralizumab for treating adult patients with anti-...

Read More
Appili gets FDA approval to expand the clinical trial of favipiravir

Biopharmaceutical major, Appili Therapeutics Inc., has reportedly announced that it has received the approval of the U.S. Food and Drug Administration (FDA) over its recently filed investigational new drug application for favipiravir, a broad-spectru...

Read More
Saudi begins Phase III clinical trials of Chinese COVID-19 vaccine

The Ministry of Health, Saudi Arabia, has reportedly announced that it will begin the third phase of clinical trials for a COVID-19 vaccine, as part of its cooperation with China’s CanSino Biologics Inc. The trials will be conducted in differen...

Read More
Amazon cleared by UK regulators to buy 16% stake in Deliveroo

The eCommerce giant Amazon has been granted permission to purchase a minority stake in the U.K-based food delivery start-up Deliveroo. The firm was able to convince regulators that the deal would not be detrimental to competition. In May of last yea...

Read More
Australia retail industry in disarray with major slump in sales

Australia’s retailers are reportedly facing a huge crisis of sorts, with the latest data depicting a massive fall in sales volumes. As the nation’s second-largest state enforces a lockdown to fight the ongoing coronavirus, Australia&rsquo...

Read More
Leedy Dental Reveals Renovations and New Dental Implant Center

The Leedy Dental, the U.S-based comprehensive dental practice with expertise in full mouth rehabilitation and implant dentistry, has reportedly completed renovation work in its practice in Abilene, TX.   Among these changes are a brand new...

Read More
UAE online marketplace Noon to enter the food delivery sector

Noon, an e-commerce platform operating in the Middle East, is reportedly planning to launch a food delivery marketplace with an aim to support the region’s food and beverage businesses during the COVID-19 pandemic. According to reports, the de...

Read More
Ecommerce conglomerate Walmart commences renewed attempts to sell Asda

Globally acclaimed retail giant Walmart had reportedly started commencing discussions to sell its Asda business, earlier this year. Walmart’s desire to divest Asda, its grocery arm in UK, is rather well-known. However, the advent of the COVID-1...

Read More
UK inks deal with Pfizer and BioNTech for potential COVID-19 vaccines

Even though the COVID-19 vaccine hasn’t been launched worldwide, it seems that leading nations are competing over who will have first access once a vaccine is ready. Recently, the government of the UK has reportedly signed an agreement with Pfi...

Read More
JCPenney to axe about 1000 jobs as part of its restructuring bid

J.C. Penney Co., Inc., a renowned American departmental store chain, has reportedly announced plans to align its workforce with the strategy of store optimization and limited store footprint. The company states that around 152 retail shops that would...

Read More
Spotify rolls out service in 13 new European markets including Russia

Audio streaming subscription service Spotify has reportedly announced the launch of its streaming services in 13 new markets spread across Europe including Belarus, Croatia, Kosovo, Albania, Bosnia & Herzegovina, North Macedonia, Serbia, Russia, ...

Read More
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19. According to sources familiar with...

Read More
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start human trials. The Indian drug regu...

Read More
Seattle Genetics reveals positive data from tisotumab vedotin trial

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing tisotumab vedotin for the treatmen...

Read More
Celltrion receives positive opinion for Remsima® SC from CHMP

Celltrion Healthcare, one of the leading biopharmaceutical companies headquartered in Incheon, South Korea, has reportedly announced that CHMP (the Committee Medicinal Products for Human Use) has recommended the company to expand the marketing author...

Read More
2020 On-site introduces new solutions for delayed clinical trials

The COVID-19 pandemic has significantly impacted the existing ecosystem of clinical trials as a whole. Except for COVID-19, most of the on-going or new clinical studies have essentially delayed or stopped in several countries across the world. In a ...

Read More
Emergency use authorization of Hydroxychloroquine revoked by U.S. FDA

The malaria drug Hydroxychloroquine has been in the headline for the past few months. The drug was hailed as the game-changer in the treatment of COVID-19 by U.S. President Donald Trump. However, the U.S.FDA (Food and Drug Administration) has reporte...

Read More
Super Retail raises USD 203 million to strengthen online capabilities

Super Retail Group Limited, the Australian company which owns and operates a portfolio of retail brands across Australia, has reportedly raised USD 203 million to strengthen its online capabilities and accelerate growth after the COVID-19 crisis. So...

Read More
China successfully launches the Haiyang-1D satellite into orbit

Haiyang-1D is the 6th satellite in the Haiyang series for Ocean observation satellites and was developed by the Chinese Academy of Space technology (CAST). This is the first successful launch for China since January. The notification of successful...

Read More
MindMed to treat cluster headaches using LSD, announces phase 2 trials

The LSD based drug will be used to treat chronic cluster headaches occurring on one side of the head or over the eye. These trials will be conducted in collaboration with Liechti Lab, University of Basil. Phase 1 trials for the drug are already un...

Read More
Huawei launches advertising campaign in UK amid security review

Chinese telecom major Huawei Technologies has reportedly announced the launch of internet campaign and a newspaper to mark two decades of its successful business in the United Kingdom. The company has also expressed its commitment to providing the be...

Read More
Greenphire introduces new budget tool to streamline clinical trails

Greenphire Inc, one of the world’s leading companies in financial lifecycle management for clinical trials, has reportedly launched a new budget development solution named EnvisiX to address the budgeting challenges experienced by CROs and glob...

Read More
Gilead’s Remdesivir improves clinical outcomes in COVID-19 patients

The novel coronavirus outbreak, which led to the on-going COVID-19 pandemic, has affected over five million people and taken the lives of over 300 thousand worldwide. But unfortunately, researchers have not been able to find treatment for this highly...

Read More
WHO halts Hydroxychloroquine clinical trial over safety concerns

The malaria drug Hydroxychloroquine has been in the headlines for the past few months. The drug was hailed as the game-changer in the treatment of COVID-19 by the Trump administration. However, the WHO (World Health Organization) has reportedly halte...

Read More
BPCL launches WhatsApp initiative to facilitate domestic gas booking

BPCL has launched a domestic gas booking facility through WhatsApp   “Bharat Gas” cylinders can be booked through a Smartline number provided by the company India’s oil marketing major Bharat Petroleum Corporation Limited...

Read More
Poxel announces preclinical outcomes on PXL770 for NASH Combinations

Poxel SA, the France-based dynamic biopharmaceutical firm developing advanced drugs for metabolic diseases, has reportedly announced the preclinical outcomes for PXL770, the main molecule in its AMPK (adenosine monophosphate-activated protein kinase)...

Read More
EMA accepts marketing authorization application for Roxadustat

Japanese pharmaceutical multinational major Astellas Pharma Inc., has announced that the marketing authorization application for anti-anemic drug Roxadustat has been accepted by the European Medicines Agency. The announcement has reportedly been made...

Read More
J.C Penney announces plans to reopen 153 stores amid a pandemic

While American department store chain J.C. Penney Company, Inc., may have got extra time with Chapter 11 bankruptcy filing, a countdown is still looming on the company’s scheduled exit from bankruptcy in November. J.C. Penney was in headlines ...

Read More
Veeva Systems unveils new app MyVeeva for clinical research sites

Veeva Systems, a renowned leader in cloud-based software for the global life sciences industry, has reportedly unveiled a new application for clinical research sites. With competencies for patient adherence, eSource, eConsent, ePRO, virtual visits as...

Read More
Massachusetts earmarks $56m to tackle food insecurity amid COVID-19

In a bid to propel the food supply chain amid COVID-19 fallout, the Baker-Polito administration has announced that state will be infusing $56m to counter food insecurities concerns in Massachusetts. Gov. Charlie Baker and Lt. Gov. Karyn Polito were ...

Read More
CapStone Holdings confirms acquisition of $50M stake in Curaleaf

CapStone Holdings, an investment and business incubator group, recently announced that it has invested about $50 million for a stake in a provider of medical as well as adult-use cannabis products across the U.S., Curaleaf. For the record, CapStone ...

Read More
University of Alberta’s cancer treatment advances to human trial

The treatment would be tested on stage four cancer patients who have not shown response to currently available treatments. University of Alberta has reportedly taken a pioneering step towards developing a treatment for cancer as it announces commenc...

Read More
UK investing in 3 clinical trials to find a cure against COVID-19

While numerous countries are currently working to find a cure for the COVID-19 outbreak, no drug trial has been able to clinically prove that it can treat the coronavirus yet. To further help this global mission of finding a cure, the UK Government h...

Read More
RRH, URMC to initiate clinical trial on a new COVID-19 vaccine

Amidst the ongoing pandemic, several medical institutes and pharma companies are diligently working on developing an antidote for the novel coronavirus. American multinational pharma company, Pfizer and its German business partner BioNTech recently m...

Read More
Shopify launches ‘Shop’ mobile app to compete with retail firm Amazon

Canadian e-commerce giant Shopify is all set to compete with Amazon with the launch of a new shopping app named ‘Shop’ that connects consumers with local businesses. Similar to Amazon, Shop consists of an extensive range of services and o...

Read More
AskBio acquires BrainVectis to expand its gene therapy portfolio

Asklepios BioPharmaceutical, Inc. (AskBio), a prominent U.S.-based clinical-stage AAV gene therapy firm, has recently announced that it has acquired BrainVectis, a Paris-based gene therapy firm renowned for its work in neurodegenerative disorders, es...

Read More
Kroger requests officials to strengthen safety standards for workers

Kroger is requesting government authorities to recognize its employees as "emergency personnel" or "extended first responders" Kroger is one of the largest grocery stores in America with over 2800 stores and 460,000 employees. ...

Read More
TikTok to donate 4 Lakh safety suits to Indian healthcare workers

Amidst lowering availability of medical equipment and safety gear in India during the current COVID-19 crisis, Chinese video-sharing company, TikTok has made a generous gesture by announcing that it will donate about 4 lakh protective hazmat sui...

Read More
Inzomelid declares positive CAPS treatment results, completes Phase I

Inflammasome biotech company Inflazome has reportedly announced the successful completion of Inzomelid’s Phase I clinical study. In addition, the firm has also declared that it has observed positive results from a CAPS (Cryopyrin-Associated Per...

Read More
Flipkart to re-open its online portal to deliver essential products

Flipkart, a renowned Indian e-commerce company, reportedly announced that it would be re-starting its online portal to deliver essential commodities across India. The company had closed down all its operations on Wednesday following the announcement ...

Read More
American Furniture Warehouse to offer engaging digital receipts

American Furniture Warehouse, one of the leading furniture retail firms in the U.S, has reportedly selected flexEngage, a prominent player in personalized transactional communications, for offering dynamic digital receipts to all American furniture i...

Read More
Bright Machines offers free automation service to develop medical devices

As the world comes together to fight against the deadly COVID-19 virus, more and more organizations are pledging their support to find a treatment for this novel disease. Recently, Bright Machines, a smart manufacturing firm, made a similar move when...

Read More
Flu drug ‘favipiravir’ hailed as effective for treating COVID-19

Medical authorities in China have reportedly announced the effectiveness of a drug called favipiravir in treating COVID-19 disease. The drug has originally been adopted for the treatment of new strains of influenza in Japan. According to reliable sou...

Read More
Amazon users may experience delays as items run out of stock

As consumers are increasingly inclining towards online shopping during the present coronavirus pandemic, U.S. e-commerce giant, Amazon.com, Inc., has warned users that they may experience some delays in product delivery as products go out of stock. ...

Read More
Shionogi launches severe thrombocytopenia treatment drug Mulpleo®

Chronic liver disease is a critical healthcare issue in the UK, with number of deaths recorded to go up by 400% since 1970. Currently, transfusion of platelets appears to be the only treatment option available to manage platelet counts, however, phar...

Read More
Innovation Pharmaceuticals eyes Phase 2 trial for Ulcerative Colitis

Phase 2 study trial will analyze the safety and efficacy of oral Brilacidin in active ulcerative colitis across 6 weeks. Brilacidin is being introduced in the form of pill as a non-corticosteroid and non-biologic drug. Innovation Pharmaceuticals...

Read More
EDCTP to grant 21.9 million euros to PAMAfrica research consortium

  EDCTP has granted the PAMAfrica research consortium 21.9 million euros over a 5 year period while the other International research partners like MMV, Novartis, and others would contribute 22 million euros. Project would include development...

Read More
Biohaven’s migraine drug NURTEC™ ODT receives FDA approval

A clinical-stage biopharmaceutical company, Biohaven Pharmaceutical Holding Company Ltd. recently announced that the FDA has approved NURTEC™ ODT, which has been developed for the acute treatment of migraine in adults. The drug is the firs...

Read More
UNMC commences clinical trial of remdesivir for treating COVID-19

A controlled, randomized clinical trial to evaluate the efficacy and safety of the investigational antiviral, remdesivir, in COVID-19 patients has reportedly commenced at the University of Nebraska Medical Center (UNMC) in Omaha. According to source...

Read More
U.S. to pour $2.5 billion to fight potential coronavirus pandemic

As the coronavirus epidemic continues to scale its way towards the West, several prominent countries across the world have started to develop novel drug solutions for fighting this disease. South Korea recently announced that it is planning to test o...

Read More
ReNeuron shares positive data from Phase 1/2a hRPC stem cell study

ReNeuron Group plc, a UK based pharmaceutical firm that specializes in cell-based therapeutics, has recently announced encouraging long-term data from its Phase 1/2a clinical study of hRPC stem cell therapy in RP (retinitis pigmentosa). Currently, R...

Read More
Recardio announces conclusion of interim analysis of Phase 2 in AMI

  The study of combination of dutogliptin and filgrastim involved approximately 120 patient enrollments. The company expects the trial completion by year end. Treatment trials across various pharmaceutical companies are on the go lately. S...

Read More
U.S. FDA gives nod to Inovio to start Phase ½ trial for INO-3107

Inovio Pharmaceuticals, Inc. has received green signal from the U.S. FDA to assess its Phase ½ trial for DNA medicine INO-3107 aimed at treating RRP (Recurrent Respiratory Papillomatosis). For the uninitiated, a rare disease inflicted by the H...

Read More
Moderna enrolls Phase 2 trial to test mRNA-1647 immunogenicity & safety

Moderna, Inc., a biotechnology company pioneering in drug discovery and development based on mRNA, has recently announced the enrollment of the Phase 2 dose-confirmation study. The data for the clinical study of mRNA vaccine against CMV (cytomegalovi...

Read More
Apple delays reopening Chinese stores following coronavirus outbreak

Technology companies worldwide are being impacted by the coronavirus outbreak currently prevailing in China. Reportedly, U.S. tech giant, Apple Inc. has recently announced extending the shutdown of its retail stores in China. Apple had earlier said ...

Read More
Fluent Commerce and BORN Group enter into a global partnership deal

BORN Group, a prominent digital agency that focuses on enterprise commerce and experience management solutions, has recently signed a global partnership deal with cloud-native distributed order management platform, Fluent Commerce. By delivering rea...

Read More
MEDISCA issues U.S. Patent 10,420,705 for planetary mixers adapter

MEDISCA Inc., a global leader in the pharmaceutical compounding industry, has recently announced the issuance of U.S. Patent 10,420,705 for an adapter used in planetary mixers. This adapter caters to customers who seek homogeneity and faster mixing t...

Read More
Grab acquires Bento Invest to offer retail wealth management services

Ridesharing firm, Grab has reportedly acquired Singapore-based robo-advisory firm, Bento Invest to enter into the retail wealth management sphere. This acquisition will enable Grab to offer retail investment and wealth management solutions to its eco...

Read More
Mesoblast submits BLA to get Ryoncil™ FDA-approved for treating SRaGVHD

Mesoblast Limited has recently announced the submission of the completed BLA (Biologics License Application) to the U.S. FDA (Food and Drug Administration) for Ryoncil™. Mesoblast is an Australian regenerative medicine company that develops cel...

Read More